Submitted by Anonymous (not verified) on 30 June 2026 - 11:30
Human medicines European public assessment report (EPAR): Doptelet, avatrombopag, Date of authorisation: 20/06/2019, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Doptelet, avatrombopag, Date of authorisation: 20/06/2019, Revision: 12, Status: Authorised